Cancer News and Research

Latest Cancer News and Research

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.

25 Jun 2010

Japanese researchers identity useful markers for early diagnosis of CMV gastritis

Cytomegalovirus (CMV) disease is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-SCT), which is widely accepted as a curative therapy for advanced hematological malignancies including leukemia and malignant lymphoma.

25 Jun 2010

Mercy Hospital signs letter of intent to sell its facility to HCA

Today, Hospital Corporation of America, together with Mercy Hospital, announced they had entered into a letter of intent for the sale of the hospital to HCA. Mercy's board of directors voted to sell the facility to HCA, citing the company's presence in South Florida and consistent provision of quality care.

25 Jun 2010

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

Fred Hutchinson Cancer Research Center, a world-renowned research and treatment institution in Seattle, has selected SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier enablement solutions, to enhance its enterprise resource planning system and improve on cost-efficiency.

25 Jun 2010

Congressional hearing explores Medicare payment issues, including permanent 'doc fix'

A House Energy and Commerce Committee hearing Wednesday ostensibly about a recent Medicare Payment Advisory Commission report veered to discussion of the so-called "doc fix." The panel's chairman, Rep. Frank Pallone, D-N.J., called the ongoing efforts to delay the 21 percent cut in Medicare physician payments "the elephant in the room" and added that the "Democrats and Republicans in the House and Senate, as well as the physician community, need to work together to develop a permanent fix to this problem that has vexed all of us for far too long.

25 Jun 2010

Researchers develop new assay test for bladder cancer

Researchers from the Danish Cancer Society and the Herlev University Hospital of Copenhagen have developed a novel assay to test for multiple tumor markers in bladder cancer.

25 Jun 2010

Automated calls can increase colon cancer screening rates by 30%: Study

Simple, automated telephone reminders can increase colon cancer screening rates by 30 percent, according to a Kaiser Permanente Center for Health Research study funded by the National Cancer Institute that appears in the July print edition of Medical Care.

25 Jun 2010

Latino population less likely to receive basic preventive tests, says study

"Prevention" is the new buzzword for health professionals and the new emphasis for containing future health care costs. Yet Latinos, who currently represent about 15 percent of the U.S. population, have the lowest level of preventive care of all racial and ethnic groups in the nation.

25 Jun 2010

Scientists report potential toxicity of nanoparticles in consumer products

Scientists are reporting that particle size affects the toxicity of zinc oxide, a material widely used in sunscreens. Particles smaller than 100 nanometers are slightly more toxic to colon cells than conventional zinc oxide. Solid zinc oxide was more toxic than equivalent amounts of soluble zinc, and direct particle to cell contact was required to cause cell death.

25 Jun 2010

Standard CRP test ineffective for detecting inflammatory bowel disease: Study

C-reactive protein (CRP) is used to assess disease activity in diverse inflammatory disorders including inflammatory bowel disease (IBD). However, in IBD, a significant number of patients present with low CRP levels despite clinically active disease.

25 Jun 2010

Researchers call for new psychological support for people living with disfigurement

Disfigurement can be a challenging and distressing experience for many of the 1 million people in the UK who have a visible difference of any kind.

25 Jun 2010

New research suggests resveratrol may inhibit pathogenic blood vessel formation

Current research suggests that resveratrol, a naturally occurring compound found in red wine, grapes, blueberries, peanuts, and other plants, inhibits pathogenic new blood vessel growth.

25 Jun 2010

Impact of oil spill on humans and wildlife

University of Rhode Island Pharmacy Professor Bongsup Cho knows there are cancer-causing chemicals in diesel fumes and cigarette smoke.

25 Jun 2010

Hydrophobic proteins may serve as biomarkers for treating colorectal cancer

Colorectal cancer, cancer of the colon and rectum, is a common cause of mortality worldwide. Statistical data showed that the number of deaths caused by colorectal cancer is increasing in both men and women.

25 Jun 2010

CXCL12/CXCR4 chemokine axis plays a critical role in pathogenesis of ulcerative colitis

Ulcerative colitis (UC) is characterized by frequent diarrheal attacks and anal bleeding. Histologic characteristics of UC are the invasion of the crypt epithelium and lamina propria by peripheral blood mononuclear cells (PBMCs), disruption of the epithelial lining, and consequently mucosal ulceration and crypt abscess formation in the bowel wall.

25 Jun 2010

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

EUREKA project E! 3371 Gene Transfer Agents has made great advances in the development of novel non-viral carriers able to introduce genetic material into the target cells.

25 Jun 2010

Devastating 21% SGR cuts to Medicare disproportionately impact cancer care

Today a group of cancer patients, oncologists, oncology nurses and practice administrators will meet with Members of Congress to speak out about the enormous burden placed by the massive Medicare cuts to U.S. cancer care, and to offer solutions.

24 Jun 2010

Patent application for tumor specific NPC-1C Antigen filed by Neogenix Oncology

Neogenix Oncology announced today that it has filed a patent application with the US Patent and Trade Office for the NPC-1C antigen. This antigen appears to be tumor specific for pancreatic and colorectal tumors.

24 Jun 2010

Cellonis' stem cells diabetes treatment helps reconstruct natural insulin production

Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients' conditions. The ongoing clinical study shows the treatment's best case could reconstruct a patient's natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to return to the normal activities non-diabetes sufferers take for granted.

24 Jun 2010

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports the successful completion of another clinical trial to validate the effectiveness of the company's technology for early identification and diagnosis of cervical cancer, in conventional cytological smears.

24 Jun 2010

Cancer News and Research

Latest Cancer News and Research

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

Japanese researchers identity useful markers for early diagnosis of CMV gastritis

Mercy Hospital signs letter of intent to sell its facility to HCA

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

Congressional hearing explores Medicare payment issues, including permanent 'doc fix'

Researchers develop new assay test for bladder cancer

Automated calls can increase colon cancer screening rates by 30%: Study

Latino population less likely to receive basic preventive tests, says study

Scientists report potential toxicity of nanoparticles in consumer products

Standard CRP test ineffective for detecting inflammatory bowel disease: Study

Researchers call for new psychological support for people living with disfigurement

New research suggests resveratrol may inhibit pathogenic blood vessel formation

Impact of oil spill on humans and wildlife

Hydrophobic proteins may serve as biomarkers for treating colorectal cancer

CXCL12/CXCR4 chemokine axis plays a critical role in pathogenesis of ulcerative colitis

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

Devastating 21% SGR cuts to Medicare disproportionately impact cancer care

Patent application for tumor specific NPC-1C Antigen filed by Neogenix Oncology

Cellonis' stem cells diabetes treatment helps reconstruct natural insulin production

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in